Recently, it has been demonstrated that HDAC2 binds to tumor suppressor p53 and augments its transcriptional activity in p53-wild-type osteosarcoma cells following DNA damage, indicating that the tumor-suppressive activity of HDAC2 may be dependent, at least in part, on p53 (41). The gene discussed is TP53; the disease is neoplasm.